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Abstract 
 
For listed agriculture companies,resource allocation decisions based on biological asset 
information of investors is related to the sustainable development.We examine the impact of 
the implementation of China Accounting Standards No.5 - Biological Assets (CAS5) on the 
value relevance of biological assets, which is essential convergence with International 
Financial Reporting Standards (IFRS), by analyzing the data from 2002 to 2016 of A-share 
listed companies in Shanghai and Shenzhen Stock Exchange. We find that, under historical 
cost-measurement model, the value relevance of the biological asset information of Chinese 
listed companies increased significantly after the implementation of CAS5. Further analysis 
shows that the value relevance of biological assets for groups under analyst following was 
higher than the others, which suggests that analyst following plays an alternative governance 
function. The results indicate that the biological asset information measured under historical 
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costs model has value relevance and provide empirical evidence from emerging market for the 
revision of IAS41 in 2014. It shows that the development of capital market information 
intermediary can enhance the value relevance of biological assets information, and facilitates 
the sustainability of agricultural enterprises in emerging market under the absence of strict 
external regulations and other infrastructures. 
 
Keywords: Biological assets. Value relevance. Historical cost 
 
1. Introduction 
 
As the largest emerging market and developing country in the world, China has always 
attached great importance to agricultural development. As the basic industry of the national 
economy, agriculture is not only a major source of raw materials for many downstream 
industries, but also its development is also related to the problem of poverty alleviation of 
farmers (World Bank, 2015), which is a prerequisite for social stability and sustainability. In 
recent years, with the rapid development of China's economy, agriculture has gradually 
become a popular investment area in many sectors. For example, the number of listed 
companies in the Shanghai Stock Exchange and Shenzhen Stock Exchange under the 
agriculture, forestry, and animal husbandry industry classification increased over time. In 
addition, the number of listed companies involving agricultural operations in other industries 
is also steadily increasing. Agricultural listed companies have become a powerful force in the 
Chinese capital market (Figure 1). The influx of huge capital provides good opportunities for 
Chinese agricultural development, but also raises higher requirements for the accounting of 
agricultural companies. Investors in capital market need information which reflect the value 
of agricultural enterprises for decision-making, and agricultural enterprises have to maintain 
high-quality accounting information to meet investors’ requirements. The major need in 
agricultural enterprises accounting is the treatment of biological assets. 
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Figure 1: Amounts of Chinese agricultural listed companies in 2002-2016 
 
Biological assets refer to animals and plants relevant to agricultural production and 
operation (IASB, 2001; China's Ministry of Finance, 2006), such as livestock, fishes, 
economic forest, and fast-growing, high-yield plantations. Biological assets are the basis for 
enterprise that engage in agricultural operations. It embodies the characteristics of the 
agricultural industry and vitality, which emphasizes the need for accounting recognition, 
measurement, and disclosure (Elad, 2004). However, the accounting research in biological 
assets has not received proper attention from both theoretical and substantive studies for a 
long time (Argils and Slof, 2001; Herbohn.K and Herbohn.J, 2006; Fischer and Marsh, 2013). 
Without accounting standards for biological assets at the national level then, it greatly affects 
the recognition of the biological assets of agricultural enterprises. In Chinese capital market, 
accounting fraud in biological assets in many listed agricultural companies, such as Silver 
Guangsha corporate limited, Lantian corporate limited, Fengle Seed corporate limited, and 
Xingfa Grassland corporate limited, have raised investors´ worry about the quality of 
accounting information of biological assets among listed companies in China. In February 
2006, based on the International Accounting Standards 41–Agriculture (IAS 41), Chinese 
Ministry of Finance released the China Accounting Standards No. 5–Biological assets 
(CAS5), and in January of 2007 implemented these standards among the listed companies. 
Chinese capital market regulators aim to further improve the quality of biological asset 
accounting information and to promote the development of agricultural enterprises in capital 
market through CAS5. An interesting question is: Does the capital market value the biological 
asset information of listed companies in China? In other words, does the biological asset 
information has any value relevance? Further, will the implementation of CAS5 help to 
improve the value relevance of biological asset information? 
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The value relevance of accounting information is a basic theoretical problem in 
accounting. Since the pioneering research of Ball and Brown (1968), it was a focus of many 
accounting theorists (Easton and Harris, 1991; Ohlson, 1995; Barth et al., 2004; Kerr, 2018; 
Huffman, 2018). The existing research focuses on the value relevance of accounting statement 
items (Ball and Brown, 1968; Easton and Harris, 1991; Ohlson, 1995; Aboody and Lev, 
1998;Barth et al., 2004; Ahmed et al., 2006; Zeng et al., 2016), value relevance of fair value 
measurement (Khurana and Kim, 2003; Christensen and Nikolaev, 2013; Huffman, 2018), 
impact of external environment on the value relevance of accounting information（Ali and 
Hwang, 2000; Hung, 2001; Aboody et al., 2002；Hung and Subramanyam, 2007; Kerr, 2018, 
and the effect of accounting information disclosure on value relevance (Francis et al., 2005; 
Venter et al., 2014; Middleton, 2015; Baboukardos and Rimmel, 2016). After the release and 
implementation of IAS41 in 2003, the value relevance issue of the fair value information of 
biological assets attracted extensive attention (Silva F et al., 2013a, 2013b; Gonalves et al., 
2017; He et al., 2018; Huffman, 2018). But there is no clear conclusion on the value relevance 
of the fair value information of biological assets from these studies. For example, Gonalves et 
al. (2017) found that the fair value measurement of biological assets had a value relevance by 
studying on 27 national samples, while He et al. (2018) found that the fair value measurement 
information of biological assets from Australian listed companies did not have the capability 
to predict. These uncertainties indicate that the value relevance of the biological asset 
accounting information is relevant with the national characteristics (Ali and Hwang, 2000; 
Hung, 2001; Kerr, 2018), and is also related to the measurement attributes of biological assets 
(Huffman, 2018). In addition, the existing studies do not consider the impact of the 
accounting standards changes, such as the implementation of IAS41. Unlike IAS41, due to the 
characteristics of the emerging and transforming economy in China, the conditions for 
measuring the fair value of biological assets are not mature. The CAS5 recommends a priority 
of historical cost measurement for biological assets, most of conclusions from previous 
studies on value relevance may not be suitable for the Chinese market. Therefore, as the 
largest developing and emerging economy in the world, there is a need to study if biological 
assets information measured under historical cost of listed companies has value relevance, and 
whether the use of CAS5 improves the value relevance of biological assets. Additionally, the 
revision of the measurement attributes for biological assets under IASB in 2014 that allows 
measurement of productive biological assets at historical cost, this study measures biological 
assets at historical cost under the Chinese market and provides empirical evidence from 
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emerging economies for revising IASB standards. 
In order to address these issues, this paper uses the data from A shares of listed 
companies in Shanghai and Shenzhen Stock Exchange from 2002 to 2016, and adopts a price 
model to study whether historical cost measurement suggested by CAS5 can improve the 
value relevance of biological asset information. We observe that, under the condition of 
historical cost measurement, biological asset information has significant value relevance after 
the implementation of CAS5, while it does not have value relevance before the 
implementation of CAS5. Using the biological assets’ classification test, the information of 
both current and non-current biological assets measured at historical cost have value 
relevance after the implementation of CAS5, while both of these do not have value relevance 
before the implementation of CAS5. After a series of robustness tests, the findings remained 
the same. Furthermore, we include analysts following on behalf of the external governance 
environment in order to conduct a group test. The results show that the groups with more 
analyst following have higher value relevance of biological assets. To be specific, the value 
relevance of biological assets has been significantly improved both before and after the 
implementation of CAS5, while the value relevance of biological assets is relatively low in 
groups with less analysts. 
This research makes the following contributions. Firstly, this article provides an 
empirical evidence of the value relevance of biological asset information after the application 
of IFRS in emerging market countries, which contributes the global convergence of IFRS. 
Since the release of IAS41, studies on biological assets mainly came from developed 
countries, such as Europe and Australia (Argils and Slof, 2001; Herbohn and Herbohn, 2006; 
Gonalves et al., 2017; He et al., 2018), those findings might not be suitable for developing 
countries (Elad, 2004). This paper provides positive feedback on the application of biological 
accounting standards from emerging market country through empirical study, which is 
committed to the global convergence of IFRS to IASB. Secondly, this paper supplements the 
literatures on the value relevance of biological assets information at historical cost 
measurement, and provides empirical evidence for the revision of IAS41 in 2014. Existing 
studies on the value relevance of biological assets mainly focus on fair value measurement 
information (Silva F et al., 2013a, 2013b; Gonalves et al., 2017; He et al., 2018; Huffman, 
2018), while emerging market countries and underdeveloped countries use historical costs to 
measure biological assets (Daly and Skaife, 2016; Bova, 2016). Moreover, IASB revised 
IAS41 in 2014 to allow productive biological assets to be measured at historical cost. 
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Therefore, the question whether historical cost measurement of biological assets in emerging 
market countries has increased the value relevance has become a concern among developers 
of accounting standards. This study provides empirical evidence on this question. Third, this 
paper supplements the literatures on the role of analysts following in the IFRS adoption 
among emerging market countries. This study finds that analysts following can become an 
alternative external governance mechanism to enhance the value relevance of biological asset 
information in emerging market countries, especially under the absence of external 
governance environment, such regulation execution, company supervision, information 
acquisition, and utilization. 
 
2. System Background And Literature Review 
2.1. System background of CAS5 in China 
 
As early as 1992, agricultural listed companies started in China, following with the 
trend that more and more listed companies were involved in agricultural operation. This 
increased the demand for agricultural activities accounting information of listed companies. 
However, China did not have a public accounting standard for the special business of 
agricultural listed companies for a long time. In the accounting system of listed companies in 
China, regardless of `Accounting system of joint-stock pilot enterprises` in early stages, or 
relatively complete `accounting system of the corporate Limited`, `Accounting Standards of 
Corporate`, and the `Accounting System of Corporate` have not provided systematic 
regulations on the accounting of biological assets. This accounting problems are only 
mentioned in the `supplementary provisions of the Accounting System of Agricultural 
Enterprises`, the notice of `the Implementation of the New Financial Accounting System by 
forestry Enterprises`, `the Financial Accounting System of national Forest and Nursery 
(Provisional)`, and `the Accounting Methods of Agricultural Enterprises`. Therefore, a 
relatively complete biological asset accounting system cannot be formed, and the information 
relevant of biological assets cannot be accurately disclosed. The accounting system of 
agricultural enterprises, which was implemented in 1993, advised that livestock and 
agricultural production costs should be recognized as inventory and become a part of the 
balance sheet, report biological assets such as plants, livestock, economic forest, and 
protected forest as construction-in-process, fixed assets, intangible assets, deferred expenses, 
and other items in the balance sheet, the different attributes and functions of biological assets 
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cannot be truly reflected, and there is no regulation on information disclosure of biological 
assets. The situation started to change in 2006. 
In order to achieve convergence with IFRS, Chinese Ministry of Finance adopted  
CAS5 in February 2006, which refers to IAS41. CAS5 was implemented within the scope of 
listed companies and other enterprises are encouraged to adopt the new standards. Biological 
assets were divided into consumable biological assets, productive biological assets, and public 
welfare biological assets in CAS5. Consumable biological assets belong to current assets, 
while productive biological assets and public welfare biological assets belong to non-current 
assets. Furthermore, the accounting information disclosure of biological assets is specified in 
detail, such as biological asset recognition conditions, biological asset measurement attribute 
selection, biological asset usage restriction, and biological asset quantity, which help 
accounting information users such as investors to easily understand the biological asset 
information. 
Based on the provisions of IAS41 and conditions in China, CAS5 categorizes three 
types of biological assets according to the use intention, and standardizes the accounting 
information on recognition, measurement, and disclosure of biological assets of Chinese 
agricultural companies. At the same time, CAS5 stipulates strict conditions for the fair value 
measurement application of biological assets. All Chinese listed companies still use historical 
cost measurement method after the implementation of CAS5, excepting one listed company 
(Morning Paper Corporate Limited) which issues both A and B shares and can adopt fair 
value measurement method. This provides us a relatively pure environment to examine the 
value relevance of historical cost measurement information and helps to eliminate the 
interference factors. CAS5 is the first specific accounting standard released by China for 
biological assets. It enables Chinese listed companies to have a unified standard of 
reorganization, measurement, and disclosure of biological assets, which standardizes the 
biological assets accounting treatment, theoretically improves the information quality of 
biological assets, and enhances the value relevance of biological asset information. But these 
still need empirical evidence to support. 
 
2.2 Literature on biological assets 
 
Biological assets are the main components of the operating assets of agricultural 
enterprises, and important resources for their business operation and development. Even 
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though the recognition, measurement and disclosure of biological assets has always been a 
problem in the theoretical and practical accounting, it has not been paid enough attention by 
the theoretical and practical circles for a long time (Argils and Slof, 2001; Herbohn and 
Herbohn, 2006; Fischer and Marsh, 2013). Without clear and unified accounting policy for 
biological assets, the effectiveness of decision-making can be highly impacted. 
The IASC formally published the IAS41 in February 2001 and announced to 
implement it since January 1, 2003. IAS41 regulates the accounting treatment of biological 
assets and government grants related to agricultural activities. IAS41 stipulates that biological 
assets should be measured at fair value, and historical cost only can be applied when the fair 
value cannot be obtained reliably. IAS41 provides a good opportunity for agricultural 
accountants to improve their status (Argils and Slof, 2001) because accounting helps to 
improve the management of agricultural enterprises and bring better performance. For 
example, comparing with those who do not prepare financial accounting reports, farmers who 
has financial reports are capable of carrying out cashflow forecasting and strengthen their 
management. Empirical studies have shown that accounting information has a significant 
influence on explaining and predicting the failure of agricultural enterprises (Argils and Slof, 
2001). However, since biological assets are measured at fair value, the implementation of 
agricultural accounting standards such as IAS41 will have a significant impact on the assets 
and profits of agricultural enterprises. Moreover, there are still many theoretical problems 
such as separation of biological assets and land assets. IAS41 is not suitable for 
underdeveloped countries (Elad, 2004). The financial performance of agricultural enterprises 
is unstable due to uncertainties of fair value (Herbohn and Herbohn, 2006; Herbohn, 2006); 
Dowling and Godfrey (2001) found that historical cost method of measuring biological assets 
was more popular among listed companies in Australia. In addition, studies have shown that 
measurement of biological assets at fair value may lead to adverse effects such as tax 
increases (Elad, 2004), pressure on dividend distribution (Herbohn, 2006),  profit 
manipulation (Herbohn, 2006, Silva et al., 2015), weaken the comparability of accounting 
information (Cairns et al., 2011), and raise the debt capital cost of related enterprises (Daly 
and Skaife, 2016). 
Some scholars consider the fair value of biological assets in a more positive way. For 
example, Argiles et al. (2011), based on the data test of Spanish companies, show that the 
adoption of historical cost measurement or fair value measurement makes no significant 
difference in predicting the future cash flow of biological assets, but the fair value 
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measurement of biological assets is more predictable for future surpluses. There are also 
scholars who believe that the selection of the measurement attributes of biological assets 
should match with the intention of asset usage (Botosan and Huffman, 2015). For example, 
Huffman (2018) finds that the value relevance of accounting information can be improved by 
matching the corresponding measurement method (fair value/ historical cost) according to the 
method of realizing the value of biological assets (exchange/ use). With the extensive 
implementation of IAS41 among listed companies, some scholars conducted empirical studies 
based on the biological asset data of the listed companies. For example, Silva et al. (2015) 
used the data of 31 listed companies in Brazil to study the impact of the fair value 
measurement of biological assets on managing profits, and observes that when the active 
market does not exist and the discounted cash flow model is used to estimate the fair value of 
biological assets, the surplus management will be increased. Using data from listed companies 
in 28 countries from 2001 to 2013, Daly and Skaife (2016) find that the debt cost of listed 
companies, which measured biological assets at fair value, is higher than those that adopted 
historical costs. Some scholars have studied the value relevance of the biological assets at fair 
value (Silva F et al., 2013a, 2013b; Gonalves et al., 2017; He et al., 2018; Huffman, 2018), 
and they mainly study the value relevance of fair value measurement information, and have 
no systematic research on the value relevance of historical cost measurement information of 
biological assets, and have not considered differences in market environment. Considering 
that China is the largest developing country and emerging market in the world, there are many 
restrictions on the fair value measurement of biological assets. Existing listed companies 
mainly use historical cost to measure biological assets. Therefore, this paper tries to examine 
the value relevance of biological asset measured at historical cost of Chinese listed 
companies. 
 
3. Theoretical Analysis and Research Assumptions 
 
One important goal of accounting information system is to provide useful information 
for decision-making. It is generally accepted that accounting information need to qualify with 
the requirements of relevance and reliability. In accounting, the term relevance means making 
a difference to a decision maker (FASB, 1984). If an accounting number impact on the value 
prediction of the stock market, it is considered as having relevance (Barth et al., 2001). In 
another word, investors use the accounting information in the process of stock evaluation. In 
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the classical valuation model, forecast cash flow, enterprise operation period, and risk return 
rate are three major factors of stock valuation. Information on biological assets, as resources 
for enterprise engaged in agricultural activities, can reflect the characteristics of the 
agricultural business activities. These characteristics have an impact on the three factors of the 
stock valuation model. If an enterprise owns an apple farm, the information disclosed in 
financial report about the apple trees owned by the company, such as the amount, tree age, 
geographical location, and area, are helpful for investors to predict the productivity, estimate 
the cash flow, and potential risks of the apple farm. Some existing empirical studies have also 
verified that stock market investors use biological asset information in the process of 
valuation (Silva F, 2013a; Gonalves, et al., 201; Huffman, 2018). However, higher quality 
accounting information can help improve the value relevance of accounting information 
(Barth et al., 2001; Shan, 2015). As mentioned before, there is no unified accounting policy 
for the accounting treatment of biological assets for Chinese listed companies before 2007, 
also there is a lack of the financial notes disclosure requirements about biological assets, 
therefore, the information quality of biological assets is quite low. After the application of 
CAS5 in 2007, there was a clear standard for the accounting treatment of biological assets for 
listed companies in China. The disclosure of biological asset information was sufficient, 
achieving convergence with IFRS and improving the value relevance of biological assets (Liu 
and Liu, 2007; Hung and Subramanyam, 2007). On the other hand, different types of 
biological assets realize economic benefits in different way, thus affecting the value relevance 
of biological assets. Huffman (2018) analyzes the differences in the companies´ use intention 
of biological assets, and believes that the use intention of current biological assets 
(consumable biological assets) is to trade, while the use intention of non-current biological 
assets (i.e. productive biological assets) is to use. Taking enterprises which adopt IAS4 as 
research samples, she finds that the value relevance of biological asset information can be 
significantly improved by using fair value to measure consumable biological assets and 
historical cost to value productive biological assets. However, Chinese listed companies use 
historical costs to measure both types of biological assets (current biological assets and non-
current biological assets). Therefore, these two types of biological assets have different value 
relevance after the application of CAS5. 
According to the above discussion, this article proposes the following hypothesis. 
H1: After the implementation of CAS5, the value relevance of biological asset 
information of Chinese listed companies will be significantly improved. 
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H1a: After the implementation of CAS5, the value relevance of non-current biological 
assets information of Chinese listed companies will be significantly improved. 
H1b: After the CAS5 implementation of CAS5, the value relevance of current biological 
assets information of Chinese listed companies will not be significantly improved. 
 
4. Research Design 
4.1. Sample selection and data base 
 
In this research, A shares of listed companies in Shanghai and Shenzhen Stock 
Exchange, which have disclosed biological asset information, are selected as research 
samples. Before 2007, according to the Agricultural Enterprise Accounting System, 
companies reported biological assets under inventory, construction projects, fixed assets, 
intangible assets, or amortization expenses, and made specific descriptions in the notes of 
financial report. Therefore, we use the balance sheet items and relevant notes disclosed from 
the Wind and CSMAR databases, and collect samples from those listed companies. Since the 
implementation of CAS5 from 2007, enterprises should report biological assets into 
consumable biological assets, productive biological assets, and public welfare biological 
assets respectively. The data is thus more complete and qualified. The related data are from 
the CSMAR database. Other data used in this research, such as financial data, stock 
transaction, and analyst following, are from the CSMAR database as well. We rejected the 
samples with missing data and finally obtained the annual observation list of 1230 companies 
from 2002 to 2016. The sample screening process is shown in Table 1.  
 
Table 1: Sample screening process 
 Sample Quantity 
Original sample: 1666 
Samples of missing analyst following data: 436 
Final sample: 1230 
 
The number of samples obtained in each year is shown in Table 2. In order to 
eliminate the impact of extreme values, winsorizing is applied on all continuous variables at 
the 1% level. The standard errors of all regression models are processed by the cluster at the 
company level. 
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Table 2: Distribution of final samples 
Year 
Number of 
Samples 
Proportion in Final 
Samples 
Proportion of all listed 
companies in the year 
2002 1 0.08% 0.08% 
2003 6 0.49% 0.47% 
2004 7 0.57% 0.51% 
2005 16 1.30% 1.18% 
2006 21 1.71% 1.51% 
2007 46 3.74% 3.15% 
2008 57 4.63% 3.61% 
2009 80 6.50% 4.77% 
2010 93 7.56% 4.63% 
2011 116 9.43% 5.08% 
2012 136 11.06% 5.56% 
2013 155 12.60% 6.39% 
2014 154 12.52% 6.23% 
2015 163 13.25% 6.15% 
2016 179 14.55% 6.14% 
Total 1230 100% -- 
 
4.2. Research model and variable definition 
 
The price model and revenue model are commonly applied in the study of accounting 
information value correlation. Since historical cost is used to measure the biological assets of 
listed companies before and after the implementation of CAS 5, the change in the reporting 
method does not impact the items in a profit report. Therefore, this paper applies the model of 
Khurana and Kim (2003), and only uses price model to study the value relevance of the 
balance sheet. The model represented by equations (1) and (2) is used to check the impact of 
CAS5 implementation on the value relevance of biological assets information measured at 
historical cost, at the same time, this paper controls the current assets, non-current assets and 
total liabilities excepting biological assets. The model is as follows: 
 
          (1) 
 
                                     (2) 
 
In the model represented in (1) and (2), Pi,t+1 are explanatory variables, indicating the 
share price of company i at the end of April in year t+1. CBA1 indicates that the number of 
biological assets listed in the current assets are divided by the total number of shares before 
2007. The data of biological assets listed in the current assets is achieved manually, according 
to the data disclosed in the inventory and deferred expenses. For samples after 2007, the value 
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of CBA1 is 0. The CBA2 indicates that the number of biological assets in the current assets 
are divided by the total number of shares after 2007. The biological assets in the current assets 
refer to the consumable biological assets. The CBA2 of the samples before 2007 is 0. The 
NCBA1 indicates that the number of biological assets in non-current assets are divided by 
total shares listed before 2007. The NCBA1 of samples after 2007 is 0. For the biological 
asset data reported in non-current assets, we collected the data manually based on the data 
disclosed in construction engineering, intangible assets, fixed assets, and long-term deferred 
expenses. The NCBA2 indicates that the number of the biological assets are divided by the 
total shares in non-current assets after 2007, which is the sum of productive biological assets 
and public welfare biological assets divided by the total number of shares. The NCBA2 of 
samples before 2007 is 0. The COA status that the amount of current assets minus the amount 
of current biological assets then divided by the total number of shares, which is expected to 
show positive correlation with the stock price. The NCOA presents that the amount of non-
current assets minus the non-current biological assets then divided by the total number of 
shares, which is expected to be positively correlated with the stock price. The DEBT indicates 
the ratio of total liabilities to total shares, which is expected to be negatively correlated with 
stock prices. The BA1 equals to the total amount of biological assets before 2007 divided by 
the total number of shares, equals to 0 after 2007, and the amount equals the sum of the CBA1 
and the NCBA1. The BA2 equals to the total amount of biological assets after 2007 divided 
by the total number of shares, it equals 0 before 2007, and the amount equals the sum of the 
CBA2 and the NCBA2. The OA represents the amount of other assets except biological assets 
divided by the total number of shares. The number equals the sum of the COA and the NCOA. 
Table 3 describes all the research variables. 
 
Table 3: Definition and calculation of variables 
Variable 
nature 
Variable 
symbol 
Variable calculation 
Interpreted 
variable 
P The share price disclosure in annual report of April 30. 
Explanation 
variable 
BA1 
Before 2007, biological assets /total number of shares;  
After 2007, 0. 
BA2 
Before 2007, 0.  
After 2007, number of biological assets / total stock. 
CBA1 
Before 2007, current biological assets / total shares;  
After 2007, 0. 
CBA2 
Before 2007, 0;  
After 2007, current biological assets / total number of shares. 
NCBA1 
Before 2007, non-current biological assets / total shares;  
After 2007, 0. 
NCBA2 Before 2007, 0;  
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After 2007, non-current biological assets / total number of shares. 
Control variable OA (Total assets -Biological assets) / Total number of shares 
COA 
(Current assets -Biological assets in current assets) / Total number 
of shares 
NCOA 
(Non-current assets -biological assets in non-current assets) / Total 
number of shares 
DEBT Total liabilities / Total number of shares 
 
5. Empirical Analysis 
5.1. Descriptive statistical analysis of main variables 
 
Table 4 is the descriptive statistics of the variable. Panel A shows the descriptive 
statistical result of the whole sample. Panel B is the sample descriptive statistics before 2007, 
while Panel C is those after 2007. As shown in the figures, the average value of P is 17.28, the 
median is 12.66, and the standard deviation is 15.42, illustrates that the difference between the 
average stock prices of the sample company in the end of April is quite large.  
 
Table 4: Descriptive statistics of research variables 
Variable 
Sample 
Size 
Average  
Standard 
deviation 
Median 
Minimum 
Value 
Maximum 
value 
Panel A: Full sample 
P 1230 17.28 15.42 12.66 1.790 148.1 
BA1 1230 0.0100 0.0979 0 0 2.353 
BA2 1230 0.280 0.622 0.0404 0 6.356 
OA 1230 9.983 8.860 7.632 0.414 99.12 
CBA1 1230 0.00191 0.0281 0 0 0.893 
CBA2 1230 0.221 0.582 0.0104 0 6.162 
COA 1230 5.761 7.198 3.872 -1.050 86.67 
NCBA1 1230 0.00811 0.0930 0 0 2.353 
NCBA2 1230 0.0587 0.175 0.000500 0 2.332 
NCOA 1230 4.223 3.748 3.041 0.00840 35.02 
DEBT 1230 5.574 7.376 3.329 0.102 81.68 
Panel B: Samples before the implementation of CAS5 in 2007 
P 51 6.684 3.727 5.700 1.790 21.93 
BA1 51 0.242 0.422 0.0934 0 2.353 
OA 51 8.461 5.234 6.985 1.811 28.43 
CBA1 51 0.0462 0.131 0.00130 0 0.893 
COA 51 4.289 3.738 3.317 0.507 17.12 
NCBA1 51 0.196 0.419 0.0616 0 2.353 
NCOA 51 4.172 3.280 2.773 1.198 19.57 
DEBT 51 4.887 4.381 3.383 0.387 24.08 
Panel C: Samples after the implementation of CAS5 in 2007 
P 1179 17.74 15.57 13.17 2.360 148.1 
BA2 1179 0.292 0.632 0.0462 0 6.356 
OA 1179 10.05 8.980 7.680 0.414 99.12 
CBA2 1179 0.230 0.593 0.0132 0 6.162 
COA 1179 5.824 7.305 3.903 -1.050 86.67 
NCBA2 1179 0.0613 0.178 0.00100 0 2.332 
NCOA 1179 4.225 3.769 3.049 0.00840 35.02 
DEBT 1179 5.604 7.479 3.324 0.102 81.68 
 
Is the biological assets measured by historical cost value-related? 
Xie, B.; Liu, M.; Randhir, T.; Yi, Y. Hu, X. 
 
Custos e @gronegócio on line - v. 16, n. 1, Jan/Mar - 2020.                                     ISSN 1808-2882 
www.custoseagronegocioonline.com.br 
 
136 
The average value of BA1 is 0.01 and the median is 0, which shows the proportion of 
samples with biological assets before 2007 is lower than 50%. The average value of BA2 is 
0.28, the median number is 0.0404, and the standard deviation is 0.622. This presents that the 
number of companies with biological assets increases significantly after the implementation 
of CAS5, but also indicates that the distance of the amount of samples´ biological assets is 
huge. According to the statistical results of the CBA1, CBA2, NCBA1, and NCBA2, sample 
companies which have biological assets differ greatly before and after 2007. After 2007, the 
number of sample companies with biological assets increased significantly and the average 
amount of biological assets raised rapidly. In terms of assets other than biological assets, the 
differences among samples are large as well, but in general, the gap is smaller than that of 
biological assets, and the amount of current assets in the sample is larger. The average value 
of DEBT is 5.574, the standard deviation is 7.376, and the median is 3.329, which states that 
the average debit of each share is 5.574. However, the average debt level of samples has 
increased since 2007, and the gap of average debt level among samples has increased as well. 
In a word, from the descriptive results, we can tell that the CAS5, which converging with 
IFRS, standardizes the accounting treatment of the biological asset information for Chinese 
A-share listed companies.  
 
5.2. Analysis of the impact of CAS5 implementation on value relevance of biological 
asset 
 
Firstly, this paper uses model (1) to examine the value relevance of the general 
biological asset information before and after CAS5 application. The Table 5 shows that the 
coefficient of the BA1 is not significant. The coefficient of the BA2 is 4.06, and is 
significantly positive at the 1% level. The coefficients of the OA and the DEBT are 
significantly positive at the 1% level as well. This explains that the biological assets owned by 
the listed company before 2007 have no significant forecast relationship with the stock price. 
However, after the implementation of CAS5 in 2007, the biological assets of the listed 
company show an effective forecast on the stock price, and the value relevance of the 
biological assets is considerably improved, which preliminarily verify the assumption 1. 
Secondly, we use model (2) to test the value relevance between the current biological 
assets and non-current biological assets information before and after the implementation of 
CAS5. As in the result shown in Table 5, the coefficient of CBA1 is not significant in terms of 
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current biological assets. The coefficient of CBA2 is 4.38 and shows significant positivity at 
the level of 1%. For non-current biological assets, the coefficient of NCBA1 is not significant. 
The coefficient of NCBA2 is 7.95 and shows significant positivity at 10% level. This 
illustrates the value relevance of current and non-current biological asset information before 
and after the implementation of CAS5 are significantly different. The value relevance of both 
current and a non-current biological asset measured at historical cost are significantly 
improved after the implementation of CAS4. The assumption 1a is preliminarily verified, but 
it is inconsistent with assumption 1b. Huffman (2018) argues that the use intention of current 
biological assets is trading, so that the information measured at fair value can improve the 
value relevance, while this research suggests that current biological assets measured at 
historical cost has value relevance. The possible explanation is that the market environment of 
emerging countries has some restrictions of the basic market trading, and there is no relatively 
reliable information about the fair value of the current biological assets. Therefore, the capital 
market investors prefer to rely on historical cost. On the other hand, the ultimate use purpose 
of current biological assets is not only limited to the trading, some current biological assets 
with other assets also produce economic benefits. As a result, the information of current 
biological assets measured at historical cost has value relevance. 
The above findings also explain that, in emerging countries where market basic 
conditions are imperfect, the value relevance of historical cost measured information of 
biological assets can also be improved through the application of accounting standards that 
converge to IFRS. When IASB revised IAS41 in 2014, it also abandoned the insistence on the 
measurement of biological assets at fair value and allowed non-current biological assets to be 
measured at historical cost. This research could provide empirical evidence from emerging 
market countries that for IASB's revision. 
 
Table 5: Impact of CAS5 implementation on value relevance of biological asset 
Information 
 Model (1) Model (2) 
 Overall biological assets Classification of biological assets 
Variable P P 
CBA1  47.37(0.83) 
CBA2  4.38 (2.65) *** 
COA  2.77 (5.28) *** 
NCBA1  4.88(0.45) 
NCBA2  7.95 (1.82) * 
NCOA  1.84 (5.70) *** 
BA1 
BA2 
OA 
8.24(1.10) 
4.06 (2.77) *** 
2.71 (7.23) *** 
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DEBT 
Constant 
-3.21 (-6.96) *** 
0.71(0.20) 
-2.93 (-5.26) *** 
3.42(0.94) 
Observations 1230 1230 
R-squared 0.38 0.37 
Year Fixed effects Yes Yes 
Industry Fixed effects Yes Yes 
 
Note: The numbers in the brackets present the corresponding t statistics. *, **, and *** present that 
at the level of 10%, 5%, and 1% are significant positivity. 
 
5.3. Robustness test 
 
In order to ensure the robustness of the results, we conducted a series of robustness 
tests. The test results are shown in Table 6 and Table 7. The findings in the main test does not 
change, and the related research conclusions are further verified. 
 
5.3.1. Perform test on group before and after 2007 respectively 
 
A regression analysis is performed on samples before and after 2007. Some values of 
certain variables are replaced by 0, which probably can affect the data distribution of 
regression samples or the model setting deviation, which can influence the conclusion of this 
paper. To eliminate the impact of these factors, we divide the samples into two groups, before 
and after 2007, for inspection. The results are listed in columns (1) and (2) in Table 6 and 
columns (1) and (2) in Table 7. It can be observed that, regardless of the overall biological 
assets or both current and non-current biological assets, the historical cost of biological assets 
information has a significant value relevance in the group after 2007, while the group before 
2007 does not have value relevance. It illustrates that the application of CAS5 significantly 
improves the value relevance of biological assets, and the research findings of the main test 
are further verified. 
 
5.3.2. Perform group test based on the importance of biological assets. 
 
As mentioned above, biological assets are the basis for enterprises to engage in 
agricultural production and operation activities. The importance of biological assets  differ for 
different types of enterprises. For example, to enterprises with high proportion of agricultural 
enterprises or biological assets, the impact of biological assets is higher on the determinants 
of enterprise’s basic value, such as the future cash flow of enterprises. Therefore, capital 
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market investors will pay more attention to the biological asset information of those 
companies. We estimate that, if biological asset information has value relevance, the value of 
biological asset information is more relevant for companies with high proportion of 
agricultural enterprises or biological assets. As a result, we divide the samples groups by the 
industry clarification: agricultural enterprises and non-agricultural enterprises, also divide 
them based on the proportion of biological assets to total assets, then perform regression. The 
results are shown in columns (3), (4), (5), and (6) in Table 6, and columns (3), (4), (5), and (6) 
in Table 7. We find that agricultural enterprises with more biological assets show higher value 
relevance of biological assets. 
 
5.3.3. Use stock price disclosed in annual report as the explanatory variable 
 
This research uses stock price in the annual report as the explanatory variable to test 
the value relevance of the biological asset information. To solid the research results, we use 
the stock price at the end of last year (PY), which is disclosed in the annual report, as the 
explanatory variable, and perform regression again. The results are shown in the column (7) 
of Table 6 and Table 7. We find that the research findings of the main test are not changed, 
which further verifies our research conclusions. 
 
Table 6: Robust test results of overall biological assets 
 (1) (2) (3) (4) (5) (6) (7) 
 Before 2007 After 2007 
Agricultura
l 
enterprises 
Non-
agricultur
al 
enterprise
s 
High 
biological 
assets 
Low 
biological 
assets 
Replace 
stock 
price 
Variable P P P P P P PY 
        
BA1 4.28  -1.51 11.02 13.35 25.31 -11.04 
 (0.65)  (-0.09) (1.18) (1.13) (0.39) (-0.62) 
BA2  4.12*** 6.85*** 1.41 4.89*** -47.95 2.10* 
  (2.79) (3.22) (1.03) (3.05) (-1.06) (1.85) 
OA 0.50 2.74*** 3.09*** 2.65*** 2.50*** 2.73*** 2.29*** 
 (1.59) (7.26) (4.98) (6.52) (5.90) (4.92) (5.39) 
DEBT -0.46 -3.26*** -3.36*** -3.14*** -2.86*** -3.14*** -2.64*** 
 (-1.42) (-6.98) (-4.16) (-6.31) (-4.83) (-4.79) (-5.25) 
Constant 9.35*** 9.72*** -1.97 3.93 -0.01 0.31 -1.57 
 (3.26) (4.11) (-0.72) (1.15) (-0.00) (0.04) (-0.44) 
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Observations 51 1179 217 1013 615 615 916 
R-squared 0.72 0.37 0.48 0.38 0.44 0.39 0.28 
Year Fixed 
effects 
Yes Yes Yes Yes Yes Yes Yes 
Industry Fixed 
effects 
Yes Yes No No Yes Yes Yes 
 
Table 7: Robust test results of classified biological assets 
 (1) (2) (3) (4) (5) (6) (7) 
 
Before 
2007 
After 
2007 
Agricultural 
enterprises 
Non-
agricultura
l 
enterprises 
High 
biological 
assets 
Low 
biological 
assets 
Replace stock 
price 
Variable P P P P P P PY 
        
CBA1 31.83  -75.16 66.61 7.17 -103.37 -30.75 
 (1.03)  (-0.69) (1.05) (0.10) (-0.50) (-0.37) 
CBA2  4.45*** 6.76*** 2.95 4.31** 32.08 2.44** 
  (2.69) (3.16) (1.61) (2.23) (0.46) (2.05) 
COA 0.66** 2.80*** 2.98*** 2.71*** 2.40*** 2.84*** 2.49*** 
 (2.11) (5.25) (3.73) (4.78) (3.06) (5.24) (4.52) 
NCBA1 10.67  -16.21 15.51 -3.98 19.04 -20.38 
 (1.07)  (-0.49) (1.13) (-0.27) (0.39) (-0.88) 
NCBA2  8.01* 6.59 4.97 7.60* 46.07 9.65** 
  (1.82) (1.51) (0.75) (1.69) (0.61) (2.34) 
NCOA 0.35 1.85*** 3.22*** 1.89*** 1.67*** 1.60*** 1.43*** 
 (1.24) (5.65) (4.18) (5.63) (3.01) (3.59) (4.25) 
DEBT -0.43 -2.97*** -3.38*** -2.92*** -2.18*** -3.02*** -2.47*** 
 (-1.64) (-5.23) (-4.05) (-4.87) (-2.63) (-5.34) (-4.51) 
Constant 7.91** 10.70*** 1.72 1.76 2.93 4.79 0.19 
 (2.45) (4.64) (0.31) (0.71) (0.70) (0.69) (0.05) 
Observations 51 1179 217 1013 615 615 916 
R-squared 0.74 0.36 0.48 0.33 0.41 0.41 0.30 
Year Fixed 
effects 
Yes Yes Yes Yes Yes Yes Yes 
Industry Fixed 
effects 
Yes Yes No No Yes Yes Yes 
 
5.3.4. Further analysis: role of analyst following 
 
Some studies find that the application of IFRS does not directly lead to the increase 
accounting information value relevance, and depends on the law-enforcement of regulation 
application (Daske et al., 2008; Christensen et al., 2013;Kerr, 2018), reporting motivation of 
company's management (Daske et al., 2008), information availability (Liu and Liu, 2007), and 
stock market efficiency (Aboody, 2002), etc. In emerging market countries, the law execution, 
information acquisition and utilization, corporate management supervision, and stock market 
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efficiency are greatly different from developed countries. As a result, the value relevance 
under IFRS applications is impacted. Eccher and Healy (2000) believe that lack of necessary 
supervision and infrastructure establishment is the reason why IFRS fails to provide more 
useful information in China. In order to improve the value relevance of biological assets 
information with the convergence of IFRS, it is important to improve the external governance 
environment. As an intermediary in capital market, financial analysts with their professions 
play roles on information production and supervision of corporate management （Chung and 
Jo, 1996; Liu, 2011; Gentry and Shen, 2013）, so that the information environment of the 
capital market is improved, the agency cost is reduced, and the value relevance of accounting 
information value is increased (Chung and Jo, 1996; Lang et al., 2004). Chung and Jo (1996) 
believe that analyst following expand investors’ awareness of the company and has a positive 
impact on the company's value in stock market. Lang et al. (2004) finds that the increase of 
analyst following could improve the stock price of companies which might face corporate 
governance problems. Kim and Shi (2012) find that the application of IFRS is beneficial to 
the firm-specific information and reducing the stock price synchronicity, while more analyst 
following strengthen the effect of IFRS’s application to reduce share price synchronization. 
Therefore, in emerging markets countries where the legal environment is imperfect, 
information acquisition and utilization are low, and the company's management lacks 
effective supervision, the analyst following can play an alternative governance role, so that 
promoting the implementation of CAS5 and improving the utilization and transfer efficiency 
of biological assets information. Therefore, the value relevance of biological asset information 
is improved. 
According to the median of the number of analysts following in each year, the sample 
is divided into two groups based on the analyst following level: high analyst following and 
low analyst following. The model (1) and model (2) are regressed respectively. Columns (1) 
and column (2) in Table 8 show the test results of the overall biological assets at different 
levels of analyst following. In the group with high analyst following, the coefficient of BA1 is 
31.23, which shows significant positivity at the 10% level. The coefficient of BA2 is 4.53, 
which shows is positivity at the level 5%. We find that, besides the implementation of CAS5, 
value relevance of biological asset is increased with the growth of analyst following, which 
suggests that analyst following helps to improve the value relevance of biological asset 
information and exerts alternative governance in emerging market countries where market 
fundamentals are imperfect. In the group with lower analyst following, the coefficient of BA1 
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is not significant, but the coefficient of BA2 is 1.99, which is significantly positive at the 5% 
level, but it is extremely lower than the coefficient (P=0.0694) of BA2 of the high analyst 
group. It shows that low analyst following does not increase the value relevance of biological 
assets. 
Columns (3) and column (4) in Table 8 show the results of the classification of 
biological assets under different levels of analyst following. From the results, we can find that 
the coefficients of the two types of biological assets, CBA2 and NCBA2, are both positive 
and significant in the group of high analyst following after the application of CAS5, while the 
coefficients of CBA1 and NCBA1 before the implementation of CAS5 are positive but not 
significant. It all enhance that high analyst following can improve the value relevance of 
biological assets. 
 
Table 8: Test results of analyst following groups 
 Overall biological assets Classification of biological assets 
 (1) (2) (3) (4) 
 
High analyst 
following 
Low analyst 
following 
High analyst 
following 
Low analyst 
following 
Variable P P P P 
     
CBA1   111.65(0.92) 2.59(0.09) 
CBA2   5.74(3.21)*** 0.71(0.69) 
COA   3.74(7.66)*** 0.91(2.32)** 
NCBA1   15.52(0.65) 0.45(0.08) 
NCBA2   11.68(1.77)* 5.23(1.44) 
NCOA   2.15(4.88)*** 0.90(3.40)*** 
BA1 31.23(1.93)* -0.56(-0.16)   
BA2 4.53(2.37)** 1.99(2.00)**   
OA 3.30(6.97)*** 1.32(7.15)***   
DEBT -4.13(-7.22)*** -1.51(-6.08)*** -3.96(-7.87)*** -1.04(-2.44)** 
Constant -11.86(-1.22) 2.37(1.20) 1.65(0.25) 3.90(1.59) 
P Value (Test: BA2) 0.0694  
Observations 636 594 636 594 
R-squared 0.42 0.34 0.38 0.40 
Year Fixed effects Yes Yes Yes Yes 
Industry Fixed effects Yes Yes Yes Yes 
 
6. Conclusion 
 
Driven by the implementation of CAS5, which complies with IFRS, this research uses 
firm-year observations of 1,230 China's A-share listed companies from 2002 to 2016 of the 
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Shanghai Stock Exchange and Shenzhen Stock Exchange, and use price model to examine 
whether the implementation of CAS5 can improve the value relevance of biological assets 
information at historical cost measurement. From the perspective of overall biological assets, 
this study finds that, implementation of CAS5 significantly improve the value relevance of 
biological asset information at historical cost. From the point of view of the classification of 
biological assets, the historical cost measurement of the current biological assets and non-
current biological assets information has value relevance after the implementation CAS5, 
while it has no value relevance before the implementation of CAS5. After a series of 
robustness tests, the findings remain the same, and the value relevance of biological assets is 
more significant in agricultural enterprises and enterprises with high proportion of biological 
assets. Further, we use different level of analyst following to simulate external governance 
and find that the increase of the analyst following will promote the value relevance of 
biological asset information before the application of CAS5 application, besides the increase 
of value relevance of the biological asset information after the application of CAS5. However, 
the value relevance of biological assets is relatively low in groups with lower analyst 
following. 
This research has the following contributions. Firstly, this article provides empirical 
evidence for value relevance of biological asset information after the application of IFRS in 
emerging market, which contributes to the global convergence of IFRS. Since the public of 
IAS41, the research on biological assets is mainly from developed regions, such as Europe 
and Australia. The market conditions of developed countries and other external environments 
that highly effects on accounting standards are different from those of emerging markets. 
Those research findings are not quite suitable for developing countries (Elad, 2004). Through 
the empirical evidence of the world's largest emerging market country, this article provides 
positive results for IASB on the application of biological asset accounting standards in 
emerging market countries, which is committed to IFRS's global convergence. Secondly, this 
paper supplements the literature on the value relevance of biological assets information and 
provides empirical evidence for the IAS41 revision in 2014. The existing research on the 
value relevance of biological assets mainly focuses on fair value measurement information, 
while emerging market and non-developed countries mainly adopt historical costs to measure 
biological assets (Hana B. et al.,2012;Daly and Skaife, 2016; Bova, 2016). IASB revised the 
IAS41 in 2014, which allow productive biological assets to be measured at historical cost. 
Therefore, the application of historical cost of biological asset information in emerging 
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market countries to improve value relevance has become a concern of IASB and other 
regulation setters. This research findings provide corresponding empirical evidence. Third, 
this paper supplements the literature on the role of analyst following in emerging market 
countries. Emerging market countries are lack of in external governance environment, such as 
law execution, corporate supervision and information acquisition and utilization, as an 
alternative external governance mechanism, analyst follow shows its governance effect and 
helps to enhance the value relevance of biological asset information. 
In conclusion, the accounting standards that converge with IFRS improve the value 
relevance of biological assets in emerging market countries. In addition, fair value 
measurement of biological assets may not be suitable when lacking basic market conditions, 
while historical cost measurement can provide accounting information which helps 
information users’ decision-making. This study provides evidence from emerging market 
countries for the revision of IAS41 in 2014. It also shows that, in emerging markets countries 
where infrastructure is imperfect, the development of capital market information 
intermediaries, such as analysts, can enhance the interpretation of accounting information, 
strengthen the supervision of enterprise management and improve the value relevance of 
biological asset information. 
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